Ohio State University leads cancer treatment trials and research.
OSU as a Network Lead Academic Participating Site for the NCI NCTN
This study is all about improving cancer treatment at Ohio State University by creating new clinical trials that help patients with cancer get better care and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10794265 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment by establishing Ohio State University (OSU) as a key site for the National Cancer Institute's (NCI) National Clinical Trials Network (NCTN). OSU faculty will engage in scientific and administrative activities, manage core labs, design clinical trials, and enroll patients in various adult cancer treatment studies. The initiative aims to leverage OSU's Comprehensive Cancer Center resources to improve patient outcomes through innovative trials and research on tumor biology.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults diagnosed with various types of cancers who are seeking advanced treatment options.
Not a fit: Patients with non-cancerous conditions or those who do not meet the eligibility criteria for the clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments and enhanced quality of life for patients.
How similar studies have performed: Previous research has shown success in similar collaborative approaches within the NCTN framework, indicating a strong potential for impactful outcomes.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Verschraegen, Claire F. — Ohio State University
- Study coordinator: Verschraegen, Claire F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.